Trials / Completed
CompletedNCT05804305
Misoprostol for NASH
Misoprostol for Non-alcoholic Steatohepatitis- a Randomized Control Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Ziauddin University · Academic / Other
- Sex
- All
- Age
- 25 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this randomised control trial is to evaluate the effect of Misoprostol in treating patients with NASH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol | Misoprostol is a prostaglandin E1 analogue |
| DRUG | Placebo | Placebo contained substance that has no therapeutic value. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2023-04-07
- Last updated
- 2023-04-07
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05804305. Inclusion in this directory is not an endorsement.